SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a ...

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

UB scientists Ram Samudrala and Zackary M. Falls talk about the new platform to make drug discovery faster and less expensive ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...

SandboxAQ releases over 5 million AI-generated protein-drug structures to accelerate drug discovery and rival lab testing.

Symbiotic.blue, a biotech looking to build an AI-driven drug discovery platform, has begun a pre-seed funding round.

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and ...

In a time of relentless AI hype and mounting global economic uncertainty, the real winners will be those who think long-term.

ZS’s India hub is reshaping global healthcare by pioneering AI and GenAI applications in drug discovery, clinical trials, and ...

SandboxAQ, an AI startup, has launched a huge dataset. It will speed up the finding of new medical treatments. The dataset ...

Scientists have unlocked new details on important receptor proteins—promising targets for the creation of novel drugs for ...